These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 638315)

  • 1. Diminishing hypotensive effect of increasing doses of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1978 Mar; 62(3):362-3. PubMed ID: 638315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute tolerance to the hypotensive effect of pindolol in spontaneously hypertensive rats (SHR)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):259-66. PubMed ID: 6141128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic and hypotensive effects of brain natriuretic peptide in anaesthetized DOCA-salt hypertensive rats.
    Kita T; Kida O; Kato J; Nakamura S; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):185-90. PubMed ID: 2721031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the hypotensive and diuretic effects of 1,4-dimorpholino-7-phenylpyrido[3,4]pyridazine (DS-511) and hydrochlorothiazide in Doca, renal and spontaneously hypertensive rats.
    Inada Y; Nishikawa K; Nagaoka A; Kikuchi S
    Arzneimittelforschung; 1977; 27(9):1663-9. PubMed ID: 579134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive relationship between the dosage of pindolol and its antihypertensive effect.
    Andrén L; Hansson L
    J Cardiovasc Pharmacol; 1982; 4(1):32-3. PubMed ID: 6176796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
    Januszewicz A; Loń S; Lapiński M; Styś A
    J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypotensive effects of diltiazem in DOCA/saline hypertensive rats (author's transl)].
    Yamaguchi I; Ikezawa K; Murata S; Narita H; Ikeo T; Sato M
    Nihon Yakurigaku Zasshi; 1979 Mar; 75(2):191-9. PubMed ID: 395050
    [No Abstract]   [Full Text] [Related]  

  • 16. Once-a-day pindolol in hypertension.
    Traub YM; Rosenfeld JB
    Clin Pharmacol Ther; 1977 May; 21(5):588-92. PubMed ID: 322923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin and the hypotensive action of captopril in DOCA salt hypertensive rats [proceedings].
    Dollery CT; Miyamori I
    Br J Pharmacol; 1980 Jan; 68(1):117P-118P. PubMed ID: 6986936
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive effect of progesterone in rats with mineralocorticoid-induced hypertension.
    Wambach G; Higgins JR
    Am J Physiol; 1979 Apr; 236(4):E366-70. PubMed ID: 434199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.